Loading...
Loading...
India's raltegravir imports from ICELAND total $835 across 3 shipments from 1 foreign suppliers. CORIPHARMA EHF leads with $835 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include VEEDA CLINICAL RESEARCH PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for raltegravir — a concentrated sourcing relationship with select suppliers from ICELAND.

CORIPHARMA EHF is the leading Raltegravir supplier from ICELAND to India, with import value of $835 across 3 shipments. The top 5 suppliers — CORIPHARMA EHF — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | CORIPHARMA EHF | $835 | 3 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | VEEDA CLINICAL RESEARCH PRIVATE LIMITED | $835 | 3 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Raltegravir suppliers from ICELAND to India include CORIPHARMA EHF. The leading supplier is CORIPHARMA EHF with import value of $835 USD across 3 shipments. India imported Raltegravir worth $835 USD from ICELAND in total across 3 shipments.
India imported Raltegravir worth $835 USD from ICELAND across 3 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Raltegravir sourced from ICELAND include VEEDA CLINICAL RESEARCH PRIVATE LIMITED. The largest buyer is VEEDA CLINICAL RESEARCH PRIVATE LIMITED with $835 in imports across 3 shipments.
The total value of Raltegravir imports from ICELAND to India is $835 USD, across 3 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists